Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Lars Lannfelt
Person

Lars Lannfelt

Tracked across 2 events · 15 articles · First seen Feb 09, 2026 · Last active Mar 11, 2026

Sentiment
30
Attention
4
Events
2
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 60
Tech
BioArctic and Eisai Present Lecanemab Data at AD/PD 2026
Professor Lars Lannfelt, co-founder of BioArctic, will present on lecanemab's mechanisms of action, underscoring his foundational work in Alzheimer's disease research and the development of lecanemab.
Mar 11, 2026 · 8 articles
4 0
Regulatory
China NMPA Grants Priority Review to Leqembi SC-AI
Professor Lars Lannfelt's discovery of the Arctic mutation in Alzheimer's disease was foundational to the development of Leqembi by BioArctic.
Feb 09, 2026 · 7 articles
Relationships (1)
BioArctic inventor ↔ Lars Lannfelt Professor Lars Lannfelt's work led to the development of Leqembi by BioArctic.
NEWSDESK
Track Lars Lannfelt live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.